Table 2.

Complications and outcomes according to severity of COVID-19.

OUTCOMES	ALL CASES (N = 40)	Low-Risk (n = 4)	Moderate-Risk (n = 27)	High-Risk (n = 9)
OUTCOMES, No. (%)
Discharged recovered	30 (75.0)	4 (100)	25 (92.6)	1 (11.1)
Discharged against medical advice	1 (2.5)	0	1 (3.7)	0
Hospitalized/Still admitted	3 (7.5)	0	1 (3.7)	2 (22.2)
Mortality	6 (15.0)	0	0	6 (66.7)
COMPLICATIONS, No. (%)
Number of patients who experienced complications	12 (30.0)	0	4 (14.8)	8 (88.9)
ARDS	8 (20.0)	0	0	8 (88.9)
Nosocomial infectiona	5 (12.5)	0	3 (11.1)	2 (22.2)
Septic shock	5 (12.5)	0	0	5 (55.6)
AKI requiring RRT	6 (15.0)	0	0	6 (66.7)
Otherb:	3 (7.5)	0	1 (3.7)	2 (22.2)
LENGTH OF STAY
Hospital LOS, survivors, days Median (IQR) min-max	n = 31 12.0 (7) 3–32	n = 3 9.0 (12) 4–16	n = 25 12.0 (7) 3–32	n = 1 14 days
Hospital LOS, non-survivors, days Median (IQR) min-max	n = 6 14.0 (11) 8–24	n = 0 –	n = 0 –	n = 6 14.0 (11) 8–24
ICU stay, No. (%)	9 (22.5)	0	1 (3.7)	8 (88.9)
Duration of ICU stay, days Median (IQR) min-max	n = 9 14.0 (11) 3–24	n = 0 –	n = 1 1 day	n = 8 15.0 (10.5) 8–24
Clinical cure, No. (%)
Yes	30 (75.0)	4 (100)	25 (92.6)	1 (11.1)
No	10 (25.0)	0	2 (7.7)	8 (88.9)
Virologic cure, No. (%)
Yes	25 (62.5)	4 (100)	19 (70.4)	2 (22.2)
No	6 (15.0)	0	5 (18.5)	1 (11.1)
Unknown	9 (22.5)	0	3 (11.1)	6 (66.7)
Time to virologic cure, days Median (IQR) min-max	n = 25 13.0 (4) 8–27	n = 4 16.0 (5) 14–24	n = 19 13.0 (6) 8–27	n = 2 19.5 (13) 13–26
Mortality, No. (%)	6 (15.0)	–	–	6 (66.7)
COVID-related	5 (12.5)	–	–	5 (55.6)
Not COVID-related	1 (2.5)	–	–	1 (11.1)

AKI – acute kidney injury, ARDS – Acute Respiratory Distress Syndrome, CRBSI – Catheter Related Bloodstream Infection HAP –Hospital Acquired Pneumonia, IQR −interquartile range, LOS – length of stay, RRT – renal replacement therapy VAP – Ventilator Associated Pneumonia.

^aVAP (3), HAP (2), CRBSI (2).

^bEncephalopathy (1), pneumomediastinum (1), pneumothorax (1).